• Login
    • Advanced search
    • Title
    • Channel
    • Module
  • Home
  • Industry
    •  

      • Aerospace, Defense, and Government Services
      • Automotive
      • Consumer
      • Manufacturing and Industrials
      • Education
      • Energy and Natural Resources
      • Financial Institutions
    •  

      • Insurance
      • Life Sciences and Health Care
      • Private Capital
      • Real Estate
      • Sports, Media and Entertainment
      • Technology and Telecoms
      • Transport and Logistics
  • Practice
    • Corporate & Finance

      • Banking and Loan Finance
      • Business Restructuring and Insolvency
      • Capital Markets
      • Corporate Governance and Public Company Representation
      • Digital Assets and Blockchain
      • Infrastructure, Energy, Resources, and Projects
      • Leveraged and Acquisition Finance
      • Mergers and Acquisitions
      • Pensions
      • Private Equity, Venture Capital and Investment Funds
      • Real Estate
      • Real Estate Investment Trusts (REITs)
      • Tax
      • Transfer Pricing
    • Global Regulatory

      • Administrative and Public Law
      • Antitrust and Competition
      • Communications, Internet, and Media
      • Education
      • Energy Regulatory
      • Environment and Natural Resources
      • Financial Services
      • Food Law
      • Gaming Law
      • Government Contracts and Public Procurement
      • Government Relations and Public Affairs
      • Health
      • Immigration
      • International Trade and Investment
      • Medical Device and Technology Regulatory
      • New Nuclear
      • Pharmaceuticals and Biotechnology Regulatory
      • Privacy and Cybersecurity
      • Space and Satellite
      • Strategic Operations, Agreements and Regulation
      • Transportation Regulatory
    • Intellectual Property

      • Copyright
      • Designs
      • Domain Names
      • IP and Technology Transactions
      • IP Enforcement
      • Patents
      • Trade Secrets and Confidential Know-how
      • Trademarks and Brands
      • Unfair Competition
    • Litigation, Arbitration, and Employment

      • Business and Human Rights
      • Construction and Engineering
      • Corporate and Securities Litigation
      • Employment
      • International Arbitration
      • Investigations, White Collar, and Fraud
      • Products Law
      • Risks, Disputes, and Litigation
  • Comparative guides
  • Engage Premium
  • Login
  • Register
Hogan Lovells Engage 5.7.7
      • Title
      • Channel
      • Module
    • Hit ENTER to search in content
    • Advanced search
    • Login
  • Home
  • Industry
    •  

      • Aerospace, Defense, and Government Services
      • Automotive
      • Consumer
      • Manufacturing and Industrials
      • Education
      • Energy and Natural Resources
      • Financial Institutions
    •  

      • Insurance
      • Life Sciences and Health Care
      • Private Capital
      • Real Estate
      • Sports, Media and Entertainment
      • Technology and Telecoms
      • Transport and Logistics
  • Practice
    • Corporate & Finance

      • Banking and Loan Finance
      • Business Restructuring and Insolvency
      • Capital Markets
      • Corporate Governance and Public Company Representation
      • Digital Assets and Blockchain
      • Infrastructure, Energy, Resources, and Projects
      • Leveraged and Acquisition Finance
      • Mergers and Acquisitions
      • Pensions
      • Private Equity, Venture Capital and Investment Funds
      • Real Estate
      • Real Estate Investment Trusts (REITs)
      • Tax
      • Transfer Pricing
    • Global Regulatory

      • Administrative and Public Law
      • Antitrust and Competition
      • Communications, Internet, and Media
      • Education
      • Energy Regulatory
      • Environment and Natural Resources
      • Financial Services
      • Food Law
      • Gaming Law
      • Government Contracts and Public Procurement
      • Government Relations and Public Affairs
      • Health
      • Immigration
      • International Trade and Investment
      • Medical Device and Technology Regulatory
      • New Nuclear
      • Pharmaceuticals and Biotechnology Regulatory
      • Privacy and Cybersecurity
      • Space and Satellite
      • Strategic Operations, Agreements and Regulation
      • Transportation Regulatory
    • Intellectual Property

      • Copyright
      • Designs
      • Domain Names
      • IP and Technology Transactions
      • IP Enforcement
      • Patents
      • Trade Secrets and Confidential Know-how
      • Trademarks and Brands
      • Unfair Competition
    • Litigation, Arbitration, and Employment

      • Business and Human Rights
      • Construction and Engineering
      • Corporate and Securities Litigation
      • Employment
      • International Arbitration
      • Investigations, White Collar, and Fraud
      • Products Law
      • Risks, Disputes, and Litigation
  • Comparative guides
  • Engage Premium
  • Login
  • Register
  1. News
  2. Regulations on the production, research, and medicinal use of cannabis in Mexico published

Regulations on the production, research, and medicinal use of cannabis in Mexico published

25 January 2021
    • Share by email
    • Share on
    • Twitter
    • LinkedIn
    • Get link
    • Get QR Code
    • Download
    • Print

On 12 January 2021, the Regulations to the General Health Law for the sanitary control of the production, research, and medicinal use of cannabis and its pharmacological derivatives (Regulations) were published in the Federal Official Gazette of Mexico.

This has as main purpose the harmonization of the applicable legal framework with respect to the amendments to the General Health Law and the Federal Criminal Code regarding cannabis matters, and as ordered by the Mexican Supreme Court in the Constitutional Claim Review Recourse 57/2019.

As part of the main provisions of the Regulations we highlight the following:

  1. The Regulations have as their main purpose the control, promotion, and sanitary surveillance of the raw materials, pharmacological derivatives, and cannabis drug products aimed for growing, manufacturing, research, and medical purposes.   
  2. The Regulations allow the (i) production, (ii) pharmacological and medical research, (iii) manufacture, (iv) importation, (v) exportation, and (vi) marketing of the cannabis and its pharmacological derivatives for preventive and therapeutic purposes.
  3. Growing, research, use, prescription, handling, importation, and distribution will be subject to strict requirements and the granting of different authorizations by the corresponding authorities.
  4. The authorities responsible for the application and interpretation of the Regulations in their different areas will be primarily the Health, Economy, Customs, and Agricultural authorities in Mexico.
  5. The importation of cannabis products will only be allowed through specific and authorized customs. Specific rules must be observed for submitting the corresponding import permits.
  6. Advertising of drug products that are subject to the Regulations will be only authorized so long as this is directed to health care providers.
  7. New functions are granted to the different governmental agencies for the application and surveillance of the Regulation.

The Regulations do not cover products with agronomic and industrial purposes, such as the control of products with large industrial uses containing cannabis derivatives of less than 1 percent of THC (e.g., food, cosmetic products, etc.).

The Regulations will have an important effect on the provisions governing real estate and agricultural property matters in Mexico, as a result of the permits granted for the planting, growing, cropping, and production of cannabis.

The Regulations will enter into force on 13 January 2021. Hogan Lovells is ready to advise you on any issue related to this publication. 

 

Authored by Juan Francisco Torres Landa, Ernesto Algaba, and Cecilia Stahlhut.

Contacts
Juan Francisco Torres Landa Ruffo
Partner
Mexico City
Ernesto Algaba Reyes
Partner
Mexico City
Cecilia Stahlhut Espinosa
Counsel
Mexico City
Languages English
Topics Cannabis, Hemp, and Cannabinoids
Countries Mexico
Delete Comment ?

Are you sure want to delete comment ?

Get link
Embed
Share by email
Get QR Code

Scan this QR Code to share this content

  • Contact us
  • Disclaimer
  • Privacy
  • Cookies
  • Legal Notices
  • Terms of Use

 

This website is operated by Hogan Lovells International LLP, whose registered office is at Atlantic House, Holborn Viaduct, London, EC1A 2FG. For further details of Hogan Lovells International LLP and the international legal practice that comprises Hogan Lovells International LLP, Hogan Lovells US LLP and their affiliated businesses ("Hogan Lovells"), please see our Legal Notices page. © 2022 Hogan Lovells.

Attorney advertising. Prior results do not guarantee a similar outcome.

Thomson Reuters HighQ Logo
© 2023 Hogan Lovells | Privacy Policy | Terms of Service